Advanced Human Imaging Limited announced the signing of a binding term sheet with Activate Health OÜ ("Activate"), an Estonia-based digital health provider.
Activate is developing a digital therapeutic platform for the prevention and early intervention of metabolic syndrome, a silent epidemic that effects nearly a third of the world's adult population. The digital therapeutic platform will provide patients and specialists with the necessary tools to address metabolic syndrome and delay the onset of chronic diseases such as cardiovascular disease and type 2 diabetes. Activate will integrate the AHI MultiScan Software Development Kit into its proprietary digital therapeutic platform. The integration will empower users of the Activate platform to track and ascertain dimensional-based risk assessments, vital signs and identify chronic disease risk. These data points will be used to support and improve Activate health audits, targeted micro-programs, and on-demand appointments with healthcare specialists. In January 2022 Activate was awarded a grant by Enterprise Estonia to expand their digital health footprint. This grant will assist in the acceleration of the integration of the AHI MultiScan digital health solution.